Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oshadi D and Oshadi R in Malignant Mesothelioma
NCT01627795Phase 2Suspended
- Sponsor
- Oshadi Drug Administration Ltd.
- Start
- Dec 2016
- Primary completion
- Aug 2018
- Modality
- Nanoparticles, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Deoxyribonuclease in Oshadi carrier, oshadi r in malignant mesothelioma, sponsored by Oshadi Drug Administration Ltd.. Started Dec 2016; status: suspended.
02
Drugs
Deoxyribonuclease in Oshadi carrieroshadi r
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT01627795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627795.